Furthermore, it suggested that pathways dysregulated in Tmem184b-mutants are enriched for those contributing to neurodegenerative diseases including Parkinson’s disease, ALS, Spinocerebellar ataxia, and Huntington’s Disease. This evidence concerns the gene TMEM184B and neurodegenerative disease.